Description
Stocrin (efavirenz) is commonly prescribed as part of combination therapy for the management of HIV infection in adults and pediatric patients. It is used in both treatment-naive patients (those who have not previously received antiretroviral therapy) and treatment-experienced patients (those who have received prior antiretroviral therapy).
The “600mg” designation refers to the dosage strength of Stocrin tablets. Each tablet contains 600 milligrams of efavirenz.
Stocrin is typically taken orally, usually once daily, with or without food. The specific dosage and regimen may vary depending on factors such as the patient’s medical history, other medications being taken, and the stage of HIV infection.
As with any medication, Stocrin can cause side effects, though they are generally uncommon. Common side effects may include dizziness, headache, trouble sleeping, nausea, diarrhea, rash, or abnormal dreams. These side effects often improve or resolve over time as the body adjusts to the medication.
Some individuals may experience more serious side effects, such as severe rash, liver problems, or psychiatric symptoms like depression or suicidal thoughts. It’s important for individuals taking Stocrin to report any new or worsening symptoms to their healthcare provider promptly.
Stocrin should always be used in combination with other antiretroviral medications as part of a comprehensive HIV treatment plan. It’s essential to take Stocrin exactly as prescribed and to follow up regularly with a healthcare provider for monitoring of HIV viral load, CD4 cell count, and any potential side effects.
